Advanced Medical Solutions Group

Advanced Medical Solutions Group Live Discussion

Live Discuss Polls Ratings Documents
Page

BigBobby20 15 May 2017

Re: New Target (Cantseewood) Where now? Probably back into the 280s, which the SP reached earlier today (283.5p) and previously just a week ago (intra day) when the final results were published. But who knows for sure? Lots of investors are no doubt surprised to see the SP holding its own and even putting on a burst, where some retracement might have been expected. With a little less than a 9% advance (at the time of writing) the SP will arrive at the magic 300p. Now there's a special milestone for everyone. I have suggested previously that the upward trend of the SP reflects the outstanding record of growth, resulting from well focused, quality products and exemplary management. New pipeline products will doubtless keep this pot boiling. Buying may now also owe something to speculation on the part of some investors that AMS must be attracting some attention from bigger players as a possible bid target. BB20

winningstreak 15 May 2017

Re: New Target Shot up somewhat too fast, will almost certainly fall back a bit.IMO,ws

Cantseethewoodsforthetrees 15 May 2017

Re: New Target Well, 274p's reached, on no news....Where to now?

Cantseethewoodsforthetrees 09 May 2017

Re: Shareholders and look like good 'quality' investors to me.

pete44 09 May 2017

Shareholders From AMS web siteShareholder AnalysisSubstantial ShareholdingsAs at 8 February 2017, the Company’s issued share capital consists of 210,474,203 ordinary shares with a nominal value of 5p each (“Ordinary Shares”, each share having equal voting rights.As at 8 February 2017 the Company’s major shareholders are:Table: “Substantial shareholdings”Shareholders Percentage of shares heldOctopus Investments Limited 8.40%Blackrock Inc 8.03%AXA SA 8.00%Hargreave Hale Ltd, Stockbrokers 5.96%Investec Group 5.44%Schroders 4.58%Aviva plc 4.41%Charles Stanley Group 3.65% Looks like these companies own nearly 50%.......interesting ( taken from AMS web site )

BigBobby20 30 Apr 2017

New Target Investec this week raises its target price for AMS to 274p.BB20

pete44 28 Apr 2017

This weeks AMS report in INV. CHRON. The launch the first US hernia surgical fixation product L/Band Fix8- will be a big target for AMS over the next few years. Expected to take 3 years to complete the clinical trials, it is exciting that the group has got the ball rolling in getting this product to market ...enjoying the growth provided by L/Band Fix8 sales in Europe, where revenue rose 69% to £1.1m in 2016.Newly launched products and overseas sales are making up for slower growth in UK........AMS 's superior products means some of the business from UK hospitals is starting to come back. The outlook is good for 2017 and beyond, which is why we rate the shares a BUY, despite their relatively high forward PE ratio of 28 times.

BigBobby20 20 Apr 2017

New man on board Welcome, Jorj. Good to have your maiden post on this board. Virtually everyone here will be of the same mind as you in their sentiments about AMS and their expectations of the company in the coming months and years. Many will tell you that this company is in a class of its own (though that's not to say the SP has no reverse gear). Re the dividend, there is no denying that it is modest as yet, but, as your research will have shown, there is a strong percentage mark up every year (which does little to impair the remarkable growth of cash in the bank). Good luck to you in your investment here.BB20

winningstreak 12 Apr 2017

Re: Frothy There is an almost wholly predicable rise/fall pattern in AMS's share price.After a steep rise of say 15%, a fall of some 10% follows, but overall the share price trends up. AMS is pure quality, the share price deserves to behigh, but currently at above 270p the sharp rise seems a little over the topto me.IMHO,ws

Jorj 12 Apr 2017

Re: Frothy I came ito AMS about six months ago on a tip. I've also been on the lookout for decent divi payers with potential for growth and AMS fitted both categories. The SP looked as if it had potential for increase and the divi was not bad. It looks like it paid off. I'm up a few grand on the deal.I hold Alliance Pharma for the same reasons. I've had Alliance for many years and the divi has been coming in. It isn't a dynamic share and has hovered round 50p for ages. However, I'm not complaining since my original buy was at 18p.Both are a good long term investment IMHO.Jorj

BigBobby20 11 Apr 2017

Re: Frothy Hi WSNo SP ever goes up for long in a straight line. First zig, then zag. The SP, as predicted, took off like a sky rocket from below the 200 day moving average at the end of January but has then exceeded most expectations and defied gravity in putting on near enough 75p to reach today's high water mark of circa 270p. Much of this rise is due, in my opinion, to the eye catching growth in revenue and profits and flow of new products, all of which reflects good management and quality products. But (unless there are forces at work that we are not aware of) investors will sooner or later feel that the shares are overbought and take some or all of their money off the table. 'Twas ever thus. In that case, the low point, in my estimation, could be around 240p. Then it all starts again....BB20

winningstreak 11 Apr 2017

Frothy Share price risen above 270p in very short time, looks somewhat frothy to me,could we see a pull-back to 250p when the excitement wears off...?IMHO,wsp.s. Does anyone here own shares in Alliance Pharma? I reckon that one couldrise by some 10% or more in coming months.

Cantseethewoodsforthetrees 10 Apr 2017

Question At what price were these new options granted?Current market price, I hope.....

BigBobby20 10 Apr 2017

New peaks for old It's very pleasing to see the SP holding its own and even tracking up to new highs. Doubtless investors recognise quality management and a development track record that will take some beating. I am also relieved to see that Games Investor has now abandoned his unexplained prediction (04.12.16) of "a growth rate in low single digits".I suppose, with 250p now scaled, that the next peak looming ahead of us has to be 300p level. That is a rise of only a touch over 16%--quite feasible over the nine months that remain in this calendar year, and likely to come sooner if we have good interims. That would translate into an average rise of no more than 1.8% per month from now until Christmas. Any bid now for the company--even a cheeky, opportunistic approach at, say, 50% higher than the current SP would take us near enough to £4.00. I cannot imagine that most investors would be happy to part with their holdings at under £4.50 (or a 75% premium to the present SP). I would be happy to read alternative predictions from fellow travellers.BB20

BigBobby20 22 Mar 2017

Re: BB20 250p beckoning Thank you for your kind words, Sunday Trader. This is a share that has worked well for me.Like many investors, I have also had my share of dogs, some of which died in the night and some which I packed off to other homes for fractions of their original buying price. However, AMS, I am pleased to say, has been a real success story. When the SP got to 252p recently, I calculated that my main holding, bought in single digits more than a decade ago, was a whisker away from 3000% to the good. I still consider AMS to be great value for money and find it difficult to identify other growth companies, with some disruptive product or technology, that are well managed (by directors who are not paying themselves a king's ransom) and that have the same to offer investors. Like you, I have left my main holding intact, partly out of fear of being wrong footed in any eventual takeover. Also because, as we know, the SP can jump far and fast and there is a risk of having to pay over the odds just to get back in. Some of my chartist friends smile at this naivety and, as you appear to know from my recent posts, I decided to act of my hunches and took up a fairly beefy tranche in early February at a time when the SP had dropped below the 200 day moving average, buying in at a touch over 200p, purely with the aim of cashing in my chips when the SP got itself back on track with normal service resumed. This is a share that reads like a book and, bang on cue, the SP duly obliged. I sold off in three lots in early March and realised an overall gain of circa 24%. I am not sure whether this leaves me looking clever or rather stupid, as I concede that jobbing in and out with my main holding at the right inflection point on the chart would have allowed me over and again to replace despatched shares with a larger number of replacement shares and would have had a wondrously compounding effect on the value of my holding. But daring do doesn't always win the day and my main body of AMS shares are safely held as a prized asset. I would be surprised if we do not see 300p by the New Year.Good luck to all fellow travellers.BB20

Page